Thousands of patients in the Netherlands who rely on medicinal cannabis are facing severe supply disruptions after the country's only legally licensed cultivation facility filed for bankruptcy. The commercial collapse has exposed critical flaws in the restricted Dutch regulatory framework and triggered emergency appeals to authorize immediate pharmaceutical imports from neighboring countries.